Independent, transparent, data first

Peptide Analysis benchmarks obesity and peptide drugs using published clinical-trial data. We are not funded by drug makers and we do not sell medication.

Our rules: every number links to a source; Phase 2 data is labelled as Phase 2 and never ranked against Phase 3; the maths behind every score is public; and corrections are logged in the changelog.